Consistent with the pro-apoptotic effects of genetic chemR23 ablation, pharmacological ablation of chemR23/CAMKK2/AMPK resulted in increased volumetric stroke lesions and expression of pro-apoptotic proteins. This evidence concerns the gene CMKLR1 and stroke disorder.